140 related articles for article (PubMed ID: 20367530)
41. Cross-linked hyaluronic acid sub-micron particles: in vitro and in vivo biodistribution study in cancer xenograft model.
Rosso F; Quagliariello V; Tortora C; Di Lazzaro A; Barbarisi A; Iaffaioli RV
J Mater Sci Mater Med; 2013 Jun; 24(6):1473-81. PubMed ID: 23471500
[TBL] [Abstract][Full Text] [Related]
42. Hyaluronic acid based self-assembling nanosystems for CD44 target mediated siRNA delivery to solid tumors.
Ganesh S; Iyer AK; Morrissey DV; Amiji MM
Biomaterials; 2013 Apr; 34(13):3489-502. PubMed ID: 23410679
[TBL] [Abstract][Full Text] [Related]
43. Hyaluronic Acid-Based Hydrogels: from a Natural Polysaccharide to Complex Networks.
Xu X; Jha AK; Harrington DA; Farach-Carson MC; Jia X
Soft Matter; 2012; 8(12):3280-3294. PubMed ID: 22419946
[TBL] [Abstract][Full Text] [Related]
44. Nanotechnology, bionanotechnology and microbial cell factories.
Villaverde A
Microb Cell Fact; 2010 Jul; 9():53. PubMed ID: 20602780
[TBL] [Abstract][Full Text] [Related]
45. Self-assembled nanoparticles based on hyaluronic acid-ceramide (HA-CE) and Pluronic® for tumor-targeted delivery of docetaxel.
Cho HJ; Yoon HY; Koo H; Ko SH; Shim JS; Lee JH; Kim K; Kwon IC; Kim DD
Biomaterials; 2011 Oct; 32(29):7181-90. PubMed ID: 21733572
[TBL] [Abstract][Full Text] [Related]
46. Hyaluronic acid coated poly(butyl cyanoacrylate) nanoparticles as anticancer drug carriers.
He M; Zhao Z; Yin L; Tang C; Yin C
Int J Pharm; 2009 May; 373(1-2):165-73. PubMed ID: 19429302
[TBL] [Abstract][Full Text] [Related]
47. Nanostructured hyaluronic acid-based materials for active delivery to cancer.
Ossipov DA
Expert Opin Drug Deliv; 2010 Jun; 7(6):681-703. PubMed ID: 20367530
[TBL] [Abstract][Full Text] [Related]
48. Target specific and long-acting delivery of protein, peptide, and nucleotide therapeutics using hyaluronic acid derivatives.
Oh EJ; Park K; Kim KS; Kim J; Yang JA; Kong JH; Lee MY; Hoffman AS; Hahn SK
J Control Release; 2010 Jan; 141(1):2-12. PubMed ID: 19758573
[TBL] [Abstract][Full Text] [Related]
49. Cationic nanoparticles for cancer therapy.
Bilensoy E
Expert Opin Drug Deliv; 2010 Jul; 7(7):795-809. PubMed ID: 20446858
[TBL] [Abstract][Full Text] [Related]
50. An insight on hyaluronic acid in drug targeting and drug delivery.
Yadav AK; Mishra P; Agrawal GP
J Drug Target; 2008 Feb; 16(2):91-107. PubMed ID: 18274931
[TBL] [Abstract][Full Text] [Related]
51.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
52.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
53.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
54.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
